WCN26-8727 IS KIDNEY BIOPSY ALWAYS NECESSARY IN ANTI-GBM DISEASE?

Read full text Summarise with VIRAT
Authors: Nada Alamri, Sara S. Almutar, Randa Alsulami
Cited by: 0

Summary

No summary yet. VIRAT can read this paper and write a plain-language summary of its aim, methods, key findings and limitations.

Summarise with VIRAT Free to try with your Science Catalogs account.

Abstract

Kidney biopsy is the gold standard for diagnosing anti–glomerular basement membrane (anti-GBM) disease, yet urgent therapy may be required when biopsy is not feasible or would delay care. In real-world practice, biopsy can be precluded by high bleeding risk, patient refusal, solitary kidney, or recent ischemic/thrombotic events where interrupting antiplatelets/anticoagulation is unsafe. Modern immunoassays detect circulating anti-GBM antibodies with high accuracy, raising whether biopsy is always required to initiate treatment.

Fields of Study & Subjects

Vasculitis and related conditions Renal Diseases and Glomerulopathies Systemic Lupus Erythematosus Research

Publication details

Journal / source
Kidney International Reports
Volume
11
Issue
4
Pages
106321–106321
Publication date
25 March 2026
Language
EN